<VariationArchive RecordType="classified" VariationID="1805990" VariationName="NM_015559.3(SETBP1):c.2087dup (p.Glu697fs)" VariationType="Duplication" Accession="VCV001805990" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-13" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1863000" VariationID="1805990">
      <GeneList>
        <Gene Symbol="SETBP1" FullName="SET binding protein 1" GeneID="26040" HGNC_ID="HGNC:15573" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44680073" stop="45068510" display_start="44680073" display_stop="45068510" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42260137" stop="42648474" display_start="42260137" display_stop="42648474" Strand="+" />
          </Location>
          <OMIM>611060</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015559.3(SETBP1):c.2087dup (p.Glu697fs)</Name>
      <CanonicalSPDI>NC_000018.10:44951422:CCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>18q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44951422" stop="44951423" display_start="44951422" display_stop="44951423" variantLength="1" positionVCF="44951422" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42531387" stop="42531388" display_start="42531387" display_stop="42531388" variantLength="1" positionVCF="42531387" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E697fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.44951427dup" Assembly="GRCh38">
            <Expression>NC_000018.10:g.44951427dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.42531392dup" Assembly="GRCh37">
            <Expression>NC_000018.9:g.42531392dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027527.2" sequenceAccession="NG_027527" sequenceVersion="2" change="g.276255dup">
            <Expression>NG_027527.2:g.276255dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379141.1" sequenceAccession="NM_001379141" sequenceVersion="1" change="c.2087dup">
            <Expression>NM_001379141.1:c.2087dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366070.1" sequenceAccession="NP_001366070" sequenceVersion="1" change="p.Glu697fs">
            <Expression>NP_001366070.1:p.Glu697fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379142.1" sequenceAccession="NM_001379142" sequenceVersion="1" change="c.2087dup">
            <Expression>NM_001379142.1:c.2087dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366071.1" sequenceAccession="NP_001366071" sequenceVersion="1" change="p.Glu697fs">
            <Expression>NP_001366071.1:p.Glu697fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410862.1" sequenceAccession="NM_001410862" sequenceVersion="1" change="c.2087dup">
            <Expression>NM_001410862.1:c.2087dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397791.1" sequenceAccession="NP_001397791" sequenceVersion="1" change="p.Glu697Argfs">
            <Expression>NP_001397791.1:p.Glu697Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015559.3" sequenceAccession="NM_015559" sequenceVersion="3" change="c.2087dup" MANESelect="true">
            <Expression>NM_015559.3:c.2087dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056374.2" sequenceAccession="NP_056374" sequenceVersion="2" change="p.Glu697fs">
            <Expression>NP_056374.2:p.Glu697fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150" sequenceAccession="LRG_1150">
            <Expression>LRG_1150:g.276255dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150t1" sequenceAccession="LRG_1150t1">
            <Expression>LRG_1150t1:c.2087dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1150p1" sequenceAccession="LRG_1150p1" change="p.Glu697fs">
            <Expression>LRG_1150p1:p.Glu697fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015559.3" sequenceAccession="NM_015559" sequenceVersion="3" change="c.2087dupC" MANESelect="true">
            <Expression>NM_015559.3:c.2087dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015559.3(SETBP1):c.2087dup (p.Glu697fs) AND Intellectual disability, autosomal dominant 29" Accession="RCV002470274" Version="1">
        <ClassifiedConditionList TraitSetID="19853">
          <ClassifiedCondition DB="MedGen" ID="C4015141">Intellectual disability, autosomal dominant 29</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25217958</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28346496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32460883</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32123" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 29</ElementValue>
                <XRef ID="MONDO:0014482" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13379" />
                <XRef ID="13379" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SETBP1 haploinsufficiency disorder (SETBP1-HD) is characterized by hypotonia and mild motor developmental delay; intellectual abilities ranging from normal to severe disability; speech and language disorder; behavioral problems (most commonly attention/concentration deficits and hyperactivity, impulsivity), and refractive errors and strabismus. Typically children with SETBP1-HD whose intellect is in the normal or borderline range (IQ 80-90) were diagnosed following genetic testing for behavioral problems and/or severe speech and language disorders (respectively: the inability to produce sounds in words correctly, and deficits in the understanding and/or expression of words and sentences). To date, 47 individuals with SETBP1-HD have been reported.</Attribute>
                <XRef ID="NBK575336" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34807554</ID>
                <ID Source="BookShelf">NBK575336</ID>
              </Citation>
              <XRef ID="436151" DB="Orphanet" />
              <XRef ID="C4015141" DB="MedGen" />
              <XRef ID="MONDO:0014482" DB="MONDO" />
              <XRef Type="MIM" ID="616078" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414780" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_015559_3_SETBP1_c_2087dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767006" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25217958</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28346496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32460883</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with autosomal dominant intellectual developmental disorder 29 (MIM#616078) and Schinzel-Giedion midface retraction syndrome (MIM#269150), respectively. The former is caused by premature termination variants, whereas the latter is caused by missense variants resulting in increased SETBP1 protein stability (PMID: 25217958, 28346496, 32460883). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETBP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_15829</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015559.3:c.2087dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616078" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5414780" TraitType="Disease" MappingType="XRef" MappingValue="616078" MappingRef="OMIM">
        <MedGen CUI="C4015141" Name="Intellectual disability, autosomal dominant 29" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

